Board Meeting7 May 2026, 07:41 pm
Alivus Life Sciences Board to Consider Audited Financial Results
AI Summary
Alivus Life Sciences Ltd has scheduled a Board of Directors meeting on May 14, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend on equity shares for the same period. The company has announced a trading window closure for designated persons from April 01, 2026, to May 16, 2026, for the purpose of approving the audited financial results.
Key Highlights
- Alivus Life Sciences board meeting set for May 14, 2026.
- Meeting to approve audited financial results for FY26.
- Board to consider recommending dividend on equity shares.
- Trading window closed from April 1 to May 16, 2026.
Price Impact
More from GLS